In middle-aged patients without overt heart disease, advanced echocardiographic parameters (particularly strain and EMD), combined with biomarkers such as galectin-3 and hsTnI, represent sensitive markers for early atrial dysfunction and AtCM. This evidence concerns the gene LGALS3 and heart disorder.